InsightfulValue
← Home

GlaxoSmithKline
GlaxoSmithKline

Pharma / Pharma and biotechnology


πŸ”§ Tools

βœ… Due Diligence

Industry Financials

How to evaluate financials of a company in the Pharma and biotechnology industry?
1. Revenue and Income: The first step in evaluating a pharma or biotech company's financials is to look at its revenue and income. This will give an overall picture of how well the company is performing financially. Look for consistent revenue growth over the past few years, along with net income that is positive and increasing.
2. Research and Development (R&D) Expenses: For pharma and biotech companies, a large portion of their revenue is often invested in research and development. Therefore, it is important to analyze the R&D expenses and track their trend over time. A high level of R&D spending may indicate a strong pipeline of drugs in development, but it can also be a sign of increased risk.
3. Patents and Intellectual Property: These are crucial for companies in the pharma and biotech industry as they protect their products from competitors. Assess the number of patents held by the company, their duration, and any upcoming expirations that may impact revenue.
4. Cash and Debt: Look at the company's balance sheet to assess its cash position and level of debt. A company with a strong cash balance and manageable debt burden is in a better financial position to weather any potential challenges.
5. Product Pipeline: It is essential to assess the company's product pipeline to determine the potential for future revenue. Evaluate the stage of development of each product, the likelihood of success, and the potential market size.
6. Marketing and Sales Expenses: Marketing and sales expenses are a significant component of a pharma or biotech company's financials. Analyze their expense trend and compare it to revenue growth to determine efficiency and effectiveness.
7. Competition: As with any industry, competition can have a significant impact on a pharma or biotech company's financials. Evaluate the competitive landscape, including key players, their products, and their market share.
8. Regulatory Environment: The pharma and biotech industry is highly regulated, and changes in regulations can have a significant impact on a company's financials. Stay updated on current and potential regulations and assess how they may affect the company's operations and financials.
9. Market Trends: Keep an eye on market trends in the pharma and biotech industry. This includes factors such as drug pricing, healthcare policies, and advancements in technology, which can impact a company's financial performance.
10. Management and Governance: Evaluate the company's leadership, their experience, and their track record in successfully bringing products to market. Good corporate governance practices are also important for the sustained success of a company.
What are the cost structures and profit margins in the Pharma and biotechnology industry?
The cost structure in the pharma and biotechnology industry is unique due to the high costs associated with research, development, and commercialization of new drugs and treatments. Below are some of the major cost components in this industry:
1. Research and Development (R&D) Costs: Developing new drugs and treatments involves extensive research and testing, which can be a significant cost for companies in this industry. R&D costs can include expenses related to clinical trials, laboratory equipment, and salaries of research personnel.
2. Marketing and Advertising Costs: Once a drug is approved, companies invest heavily in marketing and advertising to promote their products to healthcare professionals and consumers. This can include expenses such as advertising campaigns, sales teams, and physician education programs.
3. Manufacturing Costs: The production of pharmaceuticals and biotech products requires sophisticated manufacturing processes and high-quality facilities, resulting in significant costs for companies.
4. Regulatory and Compliance Costs: The pharmaceutical industry is highly regulated, and companies must adhere to strict regulatory requirements throughout the drug development process. This can result in significant costs related to regulatory submissions, compliance monitoring, and inspections.
5. Intellectual Property Costs: Companies in the pharma and biotech industry spend a considerable amount of money on acquiring and protecting patents for their products, which can be a significant cost component.
Profit margins in the pharma and biotech industry vary based on factors such as the success of new products, competition, and pricing strategies. However, research shows that the average profit margin for the pharmaceutical industry is around 16%, while for biotech companies, it can range from 0% to over 30%, depending on the stage of development of their products. Companies with blockbuster drugs or highly successful products usually have higher profit margins compared to those with a smaller product portfolio. Additionally, generic drug manufacturers tend to have lower profit margins due to higher competition and pricing pressure.
What is the size of the Pharma and biotechnology industry in terms of revenue and market share?
GlaxoSmithKline

πŸ“–πŸ‘€ Want to read more about GlaxoSmithKline?

Sign up for free or log in

πŸ™Œ Join now to get "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" at no cost

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3Mvbn VkRDBMNmt1 eFY4RFdsVX RKQjgud2Vi cCIgYWx0PS JHbGF4b1Nt aXRoS2xpbm UiIHRpdGxl PSJHbGF4b1 NtaXRoS2xp bmUiICBjbG Fzcz0iaW1n LWZsdWlkIi BoZWlnaHQ9 OTAgd2lkdG g9OTAgbG9h ZGluZz0nbG F6eScgc3R5 bGU9J2Jvcm Rlci1yYWRp dXM6IDZweD snPgoKICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdm bGV4OiAxOy B0ZXh0LWFs aWduOiBjZW 50ZXI7IG1h cmdpbi1sZW Z0OiA1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPHAg c3R5bGU9J2 ZvbnQtc2l6 ZTogMjZweD sgY29sb3I6 ICMzMzM7IG 1hcmdpbi1i b3R0b206ID E1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIPCf k5bwn5GAIF dhbnQgdG8g cmVhZCBtb3 JlIGFib3V0 IEdsYXhvU2 1pdGhLbGlu ZT8KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9c2 lnbnVwJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBiYW NrZ3JvdW5k LWNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Y29sb3I6IC NmZmY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBwYWRk aW5nOiAxMH B4IDIwcHg7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiA1 cHg7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICB0ZXh0LW RlY29yYXRp b246IG5vbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogYm 9sZDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG1hcmdp bi1yaWdodD ogMTBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRy YW5zaXRpb2 46IGJhY2tn cm91bmQtY2 9sb3IgMC4z cyBlYXNlOy cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dmVyPSd0aG lzLnN0eWxl LmJhY2tncm 91bmRDb2xv cj0iIzAwNT ZiMyInCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBvbm1v dXNlb3V0PS d0aGlzLnN0 eWxlLmJhY2 tncm91bmRD b2xvcj0iIz AwN0JGRiIn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bmb3IgZnJl ZQogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8c3Bh biBzdHlsZT 0nbWFyZ2lu OiAwIDhweD sgY29sb3I6 ICM1NTU7Jz 5vcjwvc3Bh bj4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxh IGhyZWY9J2 luZGV4LnBo cD9wYWdlPW xvZ2luJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogIzAw N0JGRjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHRleH QtZGVjb3Jh dGlvbjogdW 5kZXJsaW5l OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Zm9udC13ZW lnaHQ6IDUw MDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbG9nIG luCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCgogICAg ICAgICAgIC AgICAgICAg ICAgICA8cC BzdHlsZT0n bWFyZ2luLX RvcDogMTVw eDsgZm9udC 1zaXplOiAx M3B4OyBmb2 50LXdlaWdo dDogYm9sZD sgY29sb3I6 ICNkMzJmMm Y7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfmYwg Sm9pbiBub3 cgdG8gZ2V0 IDxpPiJUaG UgQ2hlY2ts aXN0IFZhbH VlIEludmVz dG9yIOKAlC BBIFNtYXJ0 ZXIgV2F5IH RvIFBpY2sg U3RvY2tzIj wvaT4gYXQg bm8gY29zdA ogICAgICAg ICAgICAgIC AgICAgICAg ICA8L3A+Cg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8IS0tCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxkaXYgc3 R5bGU9J21h cmdpbi10b3 A6IDEycHg7 IGZvbnQtc2 l6ZTogMTNw eDsgY29sb3 I6ICM0NDQ7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IFNpZ24gdX Agbm93IGFu ZCBnZXQgb3 VyIGZyZWUg ZUJvb2sgCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICA8Yj 5UaGUgQ2hl Y2tsaXN0IF ZhbHVlIElu dmVzdG9yIO KAlCBBIFNt YXJ0ZXIgV2 F5IHRvIFBp Y2sgU3RvY2 tzPC9iPgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgLS0+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID whLS0KICAg ICAgICAgIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nbWFyZ2 luLXRvcDog MTZweDsgZm 9udC1zaXpl OiAxNHB4Oy Bjb2xvcjog IzQ0NDsgZm 9udC1mYW1p bHk6IC1hcH BsZS1zeXN0 ZW0sIEJsaW 5rTWFjU3lz dGVtRm9udC wgU2Vnb2Ug VUksIFJvYm 90bywgSGVs dmV0aWNhIE 5ldWUsIHNh bnMtc2VyaW Y7IGxpbmUt aGVpZ2h0Oi AxLjY7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIEhh dmUgeW91IG hlYXJkIGFi b3V0IG91ci BzaG9ydCA8 c3Ryb25nIH N0eWxlPSdm b250LXdlaW dodDogNjAw Oyc+RGFpbH kgVmlkZW8g TmV3c2xldH Rlcjwvc3Ry b25nPj8KIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIDxhIG hyZWY9J2h0 dHBzOi8vd3 d3Lmluc2ln aHRmdWx2YW x1ZS5jb20v bmV3c2xldH Rlci5waHAn IHRhcmdldD 0nX2JsYW5r JyBzdHlsZT 0nY29sb3I6 ICMwMDdCRk Y7IHRleHQt ZGVjb3JhdG lvbjogbm9u ZTsgZm9udC 13ZWlnaHQ6 IDUwMDsgbW FyZ2luLWxl ZnQ6IDZweD snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIEZp bmQgb3V0IG 1vcmUKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvYT4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9kaXY+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIC0tPgog ICAgICAgIC AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg IDwvZGl2Pg ogICAgICAg ICAgICA=
How do fluctuations in input costs or external factors impact the Pharma and biotechnology industry economics?
GlaxoSmithKline

πŸ“–πŸ‘€ Want to read more about GlaxoSmithKline?

Sign up for free or log in

πŸ”“ Unlock our free guide: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3Mvbn VkRDBMNmt1 eFY4RFdsVX RKQjgud2Vi cCIgYWx0PS JHbGF4b1Nt aXRoS2xpbm UiIHRpdGxl PSJHbGF4b1 NtaXRoS2xp bmUiICBjbG Fzcz0iaW1n LWZsdWlkIi BoZWlnaHQ9 OTAgd2lkdG g9OTAgbG9h ZGluZz0nbG F6eScgc3R5 bGU9J2Jvcm Rlci1yYWRp dXM6IDZweD snPgoKICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdm bGV4OiAxOy B0ZXh0LWFs aWduOiBjZW 50ZXI7IG1h cmdpbi1sZW Z0OiA1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPHAg c3R5bGU9J2 ZvbnQtc2l6 ZTogMjZweD sgY29sb3I6 ICMzMzM7IG 1hcmdpbi1i b3R0b206ID E1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIPCf k5bwn5GAIF dhbnQgdG8g cmVhZCBtb3 JlIGFib3V0 IEdsYXhvU2 1pdGhLbGlu ZT8KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9c2 lnbnVwJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBiYW NrZ3JvdW5k LWNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Y29sb3I6IC NmZmY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBwYWRk aW5nOiAxMH B4IDIwcHg7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiA1 cHg7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICB0ZXh0LW RlY29yYXRp b246IG5vbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogYm 9sZDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG1hcmdp bi1yaWdodD ogMTBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRy YW5zaXRpb2 46IGJhY2tn cm91bmQtY2 9sb3IgMC4z cyBlYXNlOy cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dmVyPSd0aG lzLnN0eWxl LmJhY2tncm 91bmRDb2xv cj0iIzAwNT ZiMyInCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBvbm1v dXNlb3V0PS d0aGlzLnN0 eWxlLmJhY2 tncm91bmRD b2xvcj0iIz AwN0JGRiIn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bmb3IgZnJl ZQogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8c3Bh biBzdHlsZT 0nbWFyZ2lu OiAwIDhweD sgY29sb3I6 ICM1NTU7Jz 5vcjwvc3Bh bj4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxh IGhyZWY9J2 luZGV4LnBo cD9wYWdlPW xvZ2luJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogIzAw N0JGRjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHRleH QtZGVjb3Jh dGlvbjogdW 5kZXJsaW5l OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Zm9udC13ZW lnaHQ6IDUw MDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbG9nIG luCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCgogICAg ICAgICAgIC AgICAgICAg ICAgICA8cC BzdHlsZT0n bWFyZ2luLX RvcDogMTVw eDsgZm9udC 1zaXplOiAx M3B4OyBmb2 50LXdlaWdo dDogYm9sZD sgY29sb3I6 ICNkMzJmMm Y7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCflJMg VW5sb2NrIG 91ciBmcmVl IGd1aWRlOi A8aT4iVGhl IENoZWNrbG lzdCBWYWx1 ZSBJbnZlc3 RvciDigJQg QSBTbWFydG VyIFdheSB0 byBQaWNrIF N0b2NrcyI8 L2k+CiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwv cD4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwh LS0KICAgIC AgICAgICAg ICAgICAgIC AgICAgPGRp diBzdHlsZT 0nbWFyZ2lu LXRvcDogMT JweDsgZm9u dC1zaXplOi AxM3B4OyBj b2xvcjogIz Q0NDsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgU2ln biB1cCBub3 cgYW5kIGdl dCBvdXIgZn JlZSBlQm9v ayAKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IDxiPlRoZS BDaGVja2xp c3QgVmFsdW UgSW52ZXN0 b3Ig4oCUIE EgU21hcnRl ciBXYXkgdG 8gUGljayBT dG9ja3M8L2 I+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC AgICAgICAg ICAgICAtLT 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPCEtLQ ogICAgICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdt YXJnaW4tdG 9wOiAxNnB4 OyBmb250LX NpemU6IDE0 cHg7IGNvbG 9yOiAjNDQ0 OyBmb250LW ZhbWlseTog LWFwcGxlLX N5c3RlbSwg QmxpbmtNYW NTeXN0ZW1G b250LCBTZW dvZSBVSSwg Um9ib3RvLC BIZWx2ZXRp Y2EgTmV1ZS wgc2Fucy1z ZXJpZjsgbG luZS1oZWln aHQ6IDEuNj snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgSGF2ZSB5 b3UgaGVhcm QgYWJvdXQg b3VyIHNob3 J0IDxzdHJv bmcgc3R5bG U9J2ZvbnQt d2VpZ2h0Oi A2MDA7Jz5E YWlseSBWaW RlbyBOZXdz bGV0dGVyPC 9zdHJvbmc+ PwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg PGEgaHJlZj 0naHR0cHM6 Ly93d3cuaW 5zaWdodGZ1 bHZhbHVlLm NvbS9uZXdz bGV0dGVyLn BocCcgdGFy Z2V0PSdfYm xhbmsnIHN0 eWxlPSdjb2 xvcjogIzAw N0JGRjsgdG V4dC1kZWNv cmF0aW9uOi Bub25lOyBm b250LXdlaW dodDogNTAw OyBtYXJnaW 4tbGVmdDog NnB4Oyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgRmluZCBv dXQgbW9yZQ ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9hPgogICAg ICAgICAgIC AgICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgICAgICAg ICAgICAgLS 0+CiAgICAg ICAgICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg IA==
What are the big costs in the Pharma and biotechnology industry?
GlaxoSmithKline

πŸ“–πŸ‘€ Want to read more about GlaxoSmithKline?

Sign up for free or log in

πŸ†“ Discover "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free eBook!

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3Mvbn VkRDBMNmt1 eFY4RFdsVX RKQjgud2Vi cCIgYWx0PS JHbGF4b1Nt aXRoS2xpbm UiIHRpdGxl PSJHbGF4b1 NtaXRoS2xp bmUiICBjbG Fzcz0iaW1n LWZsdWlkIi BoZWlnaHQ9 OTAgd2lkdG g9OTAgbG9h ZGluZz0nbG F6eScgc3R5 bGU9J2Jvcm Rlci1yYWRp dXM6IDZweD snPgoKICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdm bGV4OiAxOy B0ZXh0LWFs aWduOiBjZW 50ZXI7IG1h cmdpbi1sZW Z0OiA1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPHAg c3R5bGU9J2 ZvbnQtc2l6 ZTogMjZweD sgY29sb3I6 ICMzMzM7IG 1hcmdpbi1i b3R0b206ID E1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIPCf k5bwn5GAIF dhbnQgdG8g cmVhZCBtb3 JlIGFib3V0 IEdsYXhvU2 1pdGhLbGlu ZT8KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9c2 lnbnVwJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBiYW NrZ3JvdW5k LWNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Y29sb3I6IC NmZmY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBwYWRk aW5nOiAxMH B4IDIwcHg7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiA1 cHg7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICB0ZXh0LW RlY29yYXRp b246IG5vbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogYm 9sZDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG1hcmdp bi1yaWdodD ogMTBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRy YW5zaXRpb2 46IGJhY2tn cm91bmQtY2 9sb3IgMC4z cyBlYXNlOy cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dmVyPSd0aG lzLnN0eWxl LmJhY2tncm 91bmRDb2xv cj0iIzAwNT ZiMyInCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBvbm1v dXNlb3V0PS d0aGlzLnN0 eWxlLmJhY2 tncm91bmRD b2xvcj0iIz AwN0JGRiIn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bmb3IgZnJl ZQogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8c3Bh biBzdHlsZT 0nbWFyZ2lu OiAwIDhweD sgY29sb3I6 ICM1NTU7Jz 5vcjwvc3Bh bj4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxh IGhyZWY9J2 luZGV4LnBo cD9wYWdlPW xvZ2luJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogIzAw N0JGRjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHRleH QtZGVjb3Jh dGlvbjogdW 5kZXJsaW5l OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Zm9udC13ZW lnaHQ6IDUw MDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbG9nIG luCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCgogICAg ICAgICAgIC AgICAgICAg ICAgICA8cC BzdHlsZT0n bWFyZ2luLX RvcDogMTVw eDsgZm9udC 1zaXplOiAx M3B4OyBmb2 50LXdlaWdo dDogYm9sZD sgY29sb3I6 ICNkMzJmMm Y7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfhpMg RGlzY292ZX IgPGk+IlRo ZSBDaGVja2 xpc3QgVmFs dWUgSW52ZX N0b3Ig4oCU IEEgU21hcn RlciBXYXkg dG8gUGljay BTdG9ja3Mi PC9pPiDigJ QgZnJlZSBl Qm9vayEKIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9wPgoKIC AgICAgICAg ICAgICAgIC AgICAgICAg PCEtLQogIC AgICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdtYXJn aW4tdG9wOi AxMnB4OyBm b250LXNpem U6IDEzcHg7 IGNvbG9yOi AjNDQ0Oyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBT aWduIHVwIG 5vdyBhbmQg Z2V0IG91ci BmcmVlIGVC b29rIAogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgPGI+VG hlIENoZWNr bGlzdCBWYW x1ZSBJbnZl c3RvciDigJ QgQSBTbWFy dGVyIFdheS B0byBQaWNr IFN0b2Nrcz wvYj4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9kaXY+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC 0tPgogICAg ICAgICAgIC AgICAgICAg ICAgICA8IS 0tCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxkaX Ygc3R5bGU9 J21hcmdpbi 10b3A6IDE2 cHg7IGZvbn Qtc2l6ZTog MTRweDsgY2 9sb3I6ICM0 NDQ7IGZvbn QtZmFtaWx5 OiAtYXBwbG Utc3lzdGVt LCBCbGlua0 1hY1N5c3Rl bUZvbnQsIF NlZ29lIFVJ LCBSb2JvdG 8sIEhlbHZl dGljYSBOZX VlLCBzYW5z LXNlcmlmOy BsaW5lLWhl aWdodDogMS 42Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBIYXZl IHlvdSBoZW FyZCBhYm91 dCBvdXIgc2 hvcnQgPHN0 cm9uZyBzdH lsZT0nZm9u dC13ZWlnaH Q6IDYwMDsn PkRhaWx5IF ZpZGVvIE5l d3NsZXR0ZX I8L3N0cm9u Zz4/CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICA8YSBocm VmPSdodHRw czovL3d3dy 5pbnNpZ2h0 ZnVsdmFsdW UuY29tL25l d3NsZXR0ZX IucGhwJyB0 YXJnZXQ9J1 9ibGFuaycg c3R5bGU9J2 NvbG9yOiAj MDA3QkZGOy B0ZXh0LWRl Y29yYXRpb2 46IG5vbmU7 IGZvbnQtd2 VpZ2h0OiA1 MDA7IG1hcm dpbi1sZWZ0 OiA2cHg7Jz 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBGaW5k IG91dCBtb3 JlCiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC A8L2E+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICAgICAg ICAgICAgIC AtLT4KICAg ICAgICAgIC AgICAgICAg ICA8L2Rpdj 4KICAgICAg ICAgICAgIC AgIDwvZGl2 PgogICAgIC AgICAgICA8 L2Rpdj4KIC AgICAgICAg ICAg
What was the average P/E ratio at the Pharma and biotechnology industry in the recent years?
GlaxoSmithKline

πŸ“–πŸ‘€ Want to read more about GlaxoSmithKline?

Sign up for free or log in

πŸ“š Your free copy of "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" is waiting

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3Mvbn VkRDBMNmt1 eFY4RFdsVX RKQjgud2Vi cCIgYWx0PS JHbGF4b1Nt aXRoS2xpbm UiIHRpdGxl PSJHbGF4b1 NtaXRoS2xp bmUiICBjbG Fzcz0iaW1n LWZsdWlkIi BoZWlnaHQ9 OTAgd2lkdG g9OTAgbG9h ZGluZz0nbG F6eScgc3R5 bGU9J2Jvcm Rlci1yYWRp dXM6IDZweD snPgoKICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdm bGV4OiAxOy B0ZXh0LWFs aWduOiBjZW 50ZXI7IG1h cmdpbi1sZW Z0OiA1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPHAg c3R5bGU9J2 ZvbnQtc2l6 ZTogMjZweD sgY29sb3I6 ICMzMzM7IG 1hcmdpbi1i b3R0b206ID E1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIPCf k5bwn5GAIF dhbnQgdG8g cmVhZCBtb3 JlIGFib3V0 IEdsYXhvU2 1pdGhLbGlu ZT8KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9c2 lnbnVwJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBiYW NrZ3JvdW5k LWNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Y29sb3I6IC NmZmY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBwYWRk aW5nOiAxMH B4IDIwcHg7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiA1 cHg7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICB0ZXh0LW RlY29yYXRp b246IG5vbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogYm 9sZDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG1hcmdp bi1yaWdodD ogMTBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRy YW5zaXRpb2 46IGJhY2tn cm91bmQtY2 9sb3IgMC4z cyBlYXNlOy cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dmVyPSd0aG lzLnN0eWxl LmJhY2tncm 91bmRDb2xv cj0iIzAwNT ZiMyInCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBvbm1v dXNlb3V0PS d0aGlzLnN0 eWxlLmJhY2 tncm91bmRD b2xvcj0iIz AwN0JGRiIn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bmb3IgZnJl ZQogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8c3Bh biBzdHlsZT 0nbWFyZ2lu OiAwIDhweD sgY29sb3I6 ICM1NTU7Jz 5vcjwvc3Bh bj4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxh IGhyZWY9J2 luZGV4LnBo cD9wYWdlPW xvZ2luJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogIzAw N0JGRjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHRleH QtZGVjb3Jh dGlvbjogdW 5kZXJsaW5l OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Zm9udC13ZW lnaHQ6IDUw MDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbG9nIG luCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCgogICAg ICAgICAgIC AgICAgICAg ICAgICA8cC BzdHlsZT0n bWFyZ2luLX RvcDogMTVw eDsgZm9udC 1zaXplOiAx M3B4OyBmb2 50LXdlaWdo dDogYm9sZD sgY29sb3I6 ICNkMzJmMm Y7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfk5og WW91ciBmcm VlIGNvcHkg b2YgPGk+Il RoZSBDaGVj a2xpc3QgVm FsdWUgSW52 ZXN0b3Ig4o CUIEEgU21h cnRlciBXYX kgdG8gUGlj ayBTdG9ja3 MiPC9pPiBp cyB3YWl0aW 5nCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvcD 4KCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwhLS 0KICAgICAg ICAgICAgIC AgICAgICAg ICAgPGRpdi BzdHlsZT0n bWFyZ2luLX RvcDogMTJw eDsgZm9udC 1zaXplOiAx M3B4OyBjb2 xvcjogIzQ0 NDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgU2lnbi B1cCBub3cg YW5kIGdldC BvdXIgZnJl ZSBlQm9vay AKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgID xiPlRoZSBD aGVja2xpc3 QgVmFsdWUg SW52ZXN0b3 Ig4oCUIEEg U21hcnRlci BXYXkgdG8g UGljayBTdG 9ja3M8L2I+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvZGl2 PgogICAgIC AgICAgICAg ICAgICAgIC AgICAtLT4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPCEtLQog ICAgICAgIC AgICAgICAg ICAgICAgIC A8ZGl2IHN0 eWxlPSdtYX JnaW4tdG9w OiAxNnB4Oy Bmb250LXNp emU6IDE0cH g7IGNvbG9y OiAjNDQ0Oy Bmb250LWZh bWlseTogLW FwcGxlLXN5 c3RlbSwgQm xpbmtNYWNT eXN0ZW1Gb2 50LCBTZWdv ZSBVSSwgUm 9ib3RvLCBI ZWx2ZXRpY2 EgTmV1ZSwg c2Fucy1zZX JpZjsgbGlu ZS1oZWlnaH Q6IDEuNjsn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg SGF2ZSB5b3 UgaGVhcmQg YWJvdXQgb3 VyIHNob3J0 IDxzdHJvbm cgc3R5bGU9 J2ZvbnQtd2 VpZ2h0OiA2 MDA7Jz5EYW lseSBWaWRl byBOZXdzbG V0dGVyPC9z dHJvbmc+Pw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgPG EgaHJlZj0n aHR0cHM6Ly 93d3cuaW5z aWdodGZ1bH ZhbHVlLmNv bS9uZXdzbG V0dGVyLnBo cCcgdGFyZ2 V0PSdfYmxh bmsnIHN0eW xlPSdjb2xv cjogIzAwN0 JGRjsgdGV4 dC1kZWNvcm F0aW9uOiBu b25lOyBmb2 50LXdlaWdo dDogNTAwOy BtYXJnaW4t bGVmdDogNn B4Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg RmluZCBvdX QgbW9yZQog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9h PgogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg ICAgICAgIC AgICAgLS0+ CiAgICAgIC AgICAgICAg ICAgICAgPC 9kaXY+CiAg ICAgICAgIC AgICAgICA8 L2Rpdj4KIC AgICAgICAg ICAgPC9kaX Y+CiAgICAg ICAgICAgIA ==
What was the average Dividend Payout Ratio ratio at the Pharma and biotechnology industry in the recent years?
GlaxoSmithKline

πŸ“–πŸ‘€ Want to read more about GlaxoSmithKline?

Sign up for free or log in

✍️ Sign up to get "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" for free

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3Mvbn VkRDBMNmt1 eFY4RFdsVX RKQjgud2Vi cCIgYWx0PS JHbGF4b1Nt aXRoS2xpbm UiIHRpdGxl PSJHbGF4b1 NtaXRoS2xp bmUiICBjbG Fzcz0iaW1n LWZsdWlkIi BoZWlnaHQ9 OTAgd2lkdG g9OTAgbG9h ZGluZz0nbG F6eScgc3R5 bGU9J2Jvcm Rlci1yYWRp dXM6IDZweD snPgoKICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdm bGV4OiAxOy B0ZXh0LWFs aWduOiBjZW 50ZXI7IG1h cmdpbi1sZW Z0OiA1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPHAg c3R5bGU9J2 ZvbnQtc2l6 ZTogMjZweD sgY29sb3I6 ICMzMzM7IG 1hcmdpbi1i b3R0b206ID E1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIPCf k5bwn5GAIF dhbnQgdG8g cmVhZCBtb3 JlIGFib3V0 IEdsYXhvU2 1pdGhLbGlu ZT8KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9c2 lnbnVwJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBiYW NrZ3JvdW5k LWNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Y29sb3I6IC NmZmY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBwYWRk aW5nOiAxMH B4IDIwcHg7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiA1 cHg7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICB0ZXh0LW RlY29yYXRp b246IG5vbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogYm 9sZDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG1hcmdp bi1yaWdodD ogMTBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRy YW5zaXRpb2 46IGJhY2tn cm91bmQtY2 9sb3IgMC4z cyBlYXNlOy cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dmVyPSd0aG lzLnN0eWxl LmJhY2tncm 91bmRDb2xv cj0iIzAwNT ZiMyInCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBvbm1v dXNlb3V0PS d0aGlzLnN0 eWxlLmJhY2 tncm91bmRD b2xvcj0iIz AwN0JGRiIn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bmb3IgZnJl ZQogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8c3Bh biBzdHlsZT 0nbWFyZ2lu OiAwIDhweD sgY29sb3I6 ICM1NTU7Jz 5vcjwvc3Bh bj4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxh IGhyZWY9J2 luZGV4LnBo cD9wYWdlPW xvZ2luJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogIzAw N0JGRjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHRleH QtZGVjb3Jh dGlvbjogdW 5kZXJsaW5l OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Zm9udC13ZW lnaHQ6IDUw MDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbG9nIG luCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCgogICAg ICAgICAgIC AgICAgICAg ICAgICA8cC BzdHlsZT0n bWFyZ2luLX RvcDogMTVw eDsgZm9udC 1zaXplOiAx M3B4OyBmb2 50LXdlaWdo dDogYm9sZD sgY29sb3I6 ICNkMzJmMm Y7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIOKcje+4 jyBTaWduIH VwIHRvIGdl dCA8aT4iVG hlIENoZWNr bGlzdCBWYW x1ZSBJbnZl c3RvciDigJ QgQSBTbWFy dGVyIFdheS B0byBQaWNr IFN0b2Nrcy I8L2k+IGZv ciBmcmVlCi AgICAgICAg ICAgICAgIC AgICAgICAg IDwvcD4KCi AgICAgICAg ICAgICAgIC AgICAgICAg IDwhLS0KIC AgICAgICAg ICAgICAgIC AgICAgICAg PGRpdiBzdH lsZT0nbWFy Z2luLXRvcD ogMTJweDsg Zm9udC1zaX plOiAxM3B4 OyBjb2xvcj ogIzQ0NDsn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bub3cgYW5k IGdldCBvdX IgZnJlZSBl Qm9vayAKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIDxiPl RoZSBDaGVj a2xpc3QgVm FsdWUgSW52 ZXN0b3Ig4o CUIEEgU21h cnRlciBXYX kgdG8gUGlj ayBTdG9ja3 M8L2I+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICAgICAg ICAgICAgIC AtLT4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC EtLQogICAg ICAgICAgIC AgICAgICAg ICAgICA8ZG l2IHN0eWxl PSdtYXJnaW 4tdG9wOiAx NnB4OyBmb2 50LXNpemU6 IDE0cHg7IG NvbG9yOiAj NDQ0OyBmb2 50LWZhbWls eTogLWFwcG xlLXN5c3Rl bSwgQmxpbm tNYWNTeXN0 ZW1Gb250LC BTZWdvZSBV SSwgUm9ib3 RvLCBIZWx2 ZXRpY2EgTm V1ZSwgc2Fu cy1zZXJpZj sgbGluZS1o ZWlnaHQ6ID EuNjsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgSGF2 ZSB5b3UgaG VhcmQgYWJv dXQgb3VyIH Nob3J0IDxz dHJvbmcgc3 R5bGU9J2Zv bnQtd2VpZ2 h0OiA2MDA7 Jz5EYWlseS BWaWRlbyBO ZXdzbGV0dG VyPC9zdHJv bmc+PwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgPGEgaH JlZj0naHR0 cHM6Ly93d3 cuaW5zaWdo dGZ1bHZhbH VlLmNvbS9u ZXdzbGV0dG VyLnBocCcg dGFyZ2V0PS dfYmxhbmsn IHN0eWxlPS djb2xvcjog IzAwN0JGRj sgdGV4dC1k ZWNvcmF0aW 9uOiBub25l OyBmb250LX dlaWdodDog NTAwOyBtYX JnaW4tbGVm dDogNnB4Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgRmlu ZCBvdXQgbW 9yZQogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9hPgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgLS0+CiAg ICAgICAgIC AgICAgICAg ICAgPC9kaX Y+CiAgICAg ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgIA==
What was the average Return on Sales ratio at the Pharma and biotechnology industry in the recent years?
GlaxoSmithKline

πŸ“–πŸ‘€ Want to read more about GlaxoSmithKline?

Sign up for free or log in

⚑ Instantly access "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3Mvbn VkRDBMNmt1 eFY4RFdsVX RKQjgud2Vi cCIgYWx0PS JHbGF4b1Nt aXRoS2xpbm UiIHRpdGxl PSJHbGF4b1 NtaXRoS2xp bmUiICBjbG Fzcz0iaW1n LWZsdWlkIi BoZWlnaHQ9 OTAgd2lkdG g9OTAgbG9h ZGluZz0nbG F6eScgc3R5 bGU9J2Jvcm Rlci1yYWRp dXM6IDZweD snPgoKICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdm bGV4OiAxOy B0ZXh0LWFs aWduOiBjZW 50ZXI7IG1h cmdpbi1sZW Z0OiA1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPHAg c3R5bGU9J2 ZvbnQtc2l6 ZTogMjZweD sgY29sb3I6 ICMzMzM7IG 1hcmdpbi1i b3R0b206ID E1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIPCf k5bwn5GAIF dhbnQgdG8g cmVhZCBtb3 JlIGFib3V0 IEdsYXhvU2 1pdGhLbGlu ZT8KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9c2 lnbnVwJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBiYW NrZ3JvdW5k LWNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Y29sb3I6IC NmZmY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBwYWRk aW5nOiAxMH B4IDIwcHg7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiA1 cHg7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICB0ZXh0LW RlY29yYXRp b246IG5vbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogYm 9sZDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG1hcmdp bi1yaWdodD ogMTBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRy YW5zaXRpb2 46IGJhY2tn cm91bmQtY2 9sb3IgMC4z cyBlYXNlOy cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dmVyPSd0aG lzLnN0eWxl LmJhY2tncm 91bmRDb2xv cj0iIzAwNT ZiMyInCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBvbm1v dXNlb3V0PS d0aGlzLnN0 eWxlLmJhY2 tncm91bmRD b2xvcj0iIz AwN0JGRiIn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bmb3IgZnJl ZQogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8c3Bh biBzdHlsZT 0nbWFyZ2lu OiAwIDhweD sgY29sb3I6 ICM1NTU7Jz 5vcjwvc3Bh bj4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxh IGhyZWY9J2 luZGV4LnBo cD9wYWdlPW xvZ2luJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogIzAw N0JGRjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHRleH QtZGVjb3Jh dGlvbjogdW 5kZXJsaW5l OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Zm9udC13ZW lnaHQ6IDUw MDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbG9nIG luCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCgogICAg ICAgICAgIC AgICAgICAg ICAgICA8cC BzdHlsZT0n bWFyZ2luLX RvcDogMTVw eDsgZm9udC 1zaXplOiAx M3B4OyBmb2 50LXdlaWdo dDogYm9sZD sgY29sb3I6 ICNkMzJmMm Y7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIOKaoSBJ bnN0YW50bH kgYWNjZXNz IDxpPiJUaG UgQ2hlY2ts aXN0IFZhbH VlIEludmVz dG9yIOKAlC BBIFNtYXJ0 ZXIgV2F5IH RvIFBpY2sg U3RvY2tzIj wvaT4g4oCU IGZyZWUhCi AgICAgICAg ICAgICAgIC AgICAgICAg IDwvcD4KCi AgICAgICAg ICAgICAgIC AgICAgICAg IDwhLS0KIC AgICAgICAg ICAgICAgIC AgICAgICAg PGRpdiBzdH lsZT0nbWFy Z2luLXRvcD ogMTJweDsg Zm9udC1zaX plOiAxM3B4 OyBjb2xvcj ogIzQ0NDsn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bub3cgYW5k IGdldCBvdX IgZnJlZSBl Qm9vayAKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIDxiPl RoZSBDaGVj a2xpc3QgVm FsdWUgSW52 ZXN0b3Ig4o CUIEEgU21h cnRlciBXYX kgdG8gUGlj ayBTdG9ja3 M8L2I+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICAgICAg ICAgICAgIC AtLT4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC EtLQogICAg ICAgICAgIC AgICAgICAg ICAgICA8ZG l2IHN0eWxl PSdtYXJnaW 4tdG9wOiAx NnB4OyBmb2 50LXNpemU6 IDE0cHg7IG NvbG9yOiAj NDQ0OyBmb2 50LWZhbWls eTogLWFwcG xlLXN5c3Rl bSwgQmxpbm tNYWNTeXN0 ZW1Gb250LC BTZWdvZSBV SSwgUm9ib3 RvLCBIZWx2 ZXRpY2EgTm V1ZSwgc2Fu cy1zZXJpZj sgbGluZS1o ZWlnaHQ6ID EuNjsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgSGF2 ZSB5b3UgaG VhcmQgYWJv dXQgb3VyIH Nob3J0IDxz dHJvbmcgc3 R5bGU9J2Zv bnQtd2VpZ2 h0OiA2MDA7 Jz5EYWlseS BWaWRlbyBO ZXdzbGV0dG VyPC9zdHJv bmc+PwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgPGEgaH JlZj0naHR0 cHM6Ly93d3 cuaW5zaWdo dGZ1bHZhbH VlLmNvbS9u ZXdzbGV0dG VyLnBocCcg dGFyZ2V0PS dfYmxhbmsn IHN0eWxlPS djb2xvcjog IzAwN0JGRj sgdGV4dC1k ZWNvcmF0aW 9uOiBub25l OyBmb250LX dlaWdodDog NTAwOyBtYX JnaW4tbGVm dDogNnB4Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgRmlu ZCBvdXQgbW 9yZQogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9hPgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgLS0+CiAg ICAgICAgIC AgICAgICAg ICAgPC9kaX Y+CiAgICAg ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgIA==
What was the average Return on Assets ratio at the Pharma and biotechnology industry in the recent years?
GlaxoSmithKline

πŸ“–πŸ‘€ Want to read more about GlaxoSmithKline?

Sign up for free or log in

πŸ“š Your free copy of "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" is waiting

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3Mvbn VkRDBMNmt1 eFY4RFdsVX RKQjgud2Vi cCIgYWx0PS JHbGF4b1Nt aXRoS2xpbm UiIHRpdGxl PSJHbGF4b1 NtaXRoS2xp bmUiICBjbG Fzcz0iaW1n LWZsdWlkIi BoZWlnaHQ9 OTAgd2lkdG g9OTAgbG9h ZGluZz0nbG F6eScgc3R5 bGU9J2Jvcm Rlci1yYWRp dXM6IDZweD snPgoKICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdm bGV4OiAxOy B0ZXh0LWFs aWduOiBjZW 50ZXI7IG1h cmdpbi1sZW Z0OiA1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPHAg c3R5bGU9J2 ZvbnQtc2l6 ZTogMjZweD sgY29sb3I6 ICMzMzM7IG 1hcmdpbi1i b3R0b206ID E1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIPCf k5bwn5GAIF dhbnQgdG8g cmVhZCBtb3 JlIGFib3V0 IEdsYXhvU2 1pdGhLbGlu ZT8KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9c2 lnbnVwJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBiYW NrZ3JvdW5k LWNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Y29sb3I6IC NmZmY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBwYWRk aW5nOiAxMH B4IDIwcHg7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiA1 cHg7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICB0ZXh0LW RlY29yYXRp b246IG5vbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogYm 9sZDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG1hcmdp bi1yaWdodD ogMTBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRy YW5zaXRpb2 46IGJhY2tn cm91bmQtY2 9sb3IgMC4z cyBlYXNlOy cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dmVyPSd0aG lzLnN0eWxl LmJhY2tncm 91bmRDb2xv cj0iIzAwNT ZiMyInCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBvbm1v dXNlb3V0PS d0aGlzLnN0 eWxlLmJhY2 tncm91bmRD b2xvcj0iIz AwN0JGRiIn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bmb3IgZnJl ZQogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8c3Bh biBzdHlsZT 0nbWFyZ2lu OiAwIDhweD sgY29sb3I6 ICM1NTU7Jz 5vcjwvc3Bh bj4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxh IGhyZWY9J2 luZGV4LnBo cD9wYWdlPW xvZ2luJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogIzAw N0JGRjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHRleH QtZGVjb3Jh dGlvbjogdW 5kZXJsaW5l OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Zm9udC13ZW lnaHQ6IDUw MDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbG9nIG luCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCgogICAg ICAgICAgIC AgICAgICAg ICAgICA8cC BzdHlsZT0n bWFyZ2luLX RvcDogMTVw eDsgZm9udC 1zaXplOiAx M3B4OyBmb2 50LXdlaWdo dDogYm9sZD sgY29sb3I6 ICNkMzJmMm Y7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfk5og WW91ciBmcm VlIGNvcHkg b2YgPGk+Il RoZSBDaGVj a2xpc3QgVm FsdWUgSW52 ZXN0b3Ig4o CUIEEgU21h cnRlciBXYX kgdG8gUGlj ayBTdG9ja3 MiPC9pPiBp cyB3YWl0aW 5nCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvcD 4KCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwhLS 0KICAgICAg ICAgICAgIC AgICAgICAg ICAgPGRpdi BzdHlsZT0n bWFyZ2luLX RvcDogMTJw eDsgZm9udC 1zaXplOiAx M3B4OyBjb2 xvcjogIzQ0 NDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgU2lnbi B1cCBub3cg YW5kIGdldC BvdXIgZnJl ZSBlQm9vay AKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgID xiPlRoZSBD aGVja2xpc3 QgVmFsdWUg SW52ZXN0b3 Ig4oCUIEEg U21hcnRlci BXYXkgdG8g UGljayBTdG 9ja3M8L2I+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvZGl2 PgogICAgIC AgICAgICAg ICAgICAgIC AgICAtLT4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPCEtLQog ICAgICAgIC AgICAgICAg ICAgICAgIC A8ZGl2IHN0 eWxlPSdtYX JnaW4tdG9w OiAxNnB4Oy Bmb250LXNp emU6IDE0cH g7IGNvbG9y OiAjNDQ0Oy Bmb250LWZh bWlseTogLW FwcGxlLXN5 c3RlbSwgQm xpbmtNYWNT eXN0ZW1Gb2 50LCBTZWdv ZSBVSSwgUm 9ib3RvLCBI ZWx2ZXRpY2 EgTmV1ZSwg c2Fucy1zZX JpZjsgbGlu ZS1oZWlnaH Q6IDEuNjsn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg SGF2ZSB5b3 UgaGVhcmQg YWJvdXQgb3 VyIHNob3J0 IDxzdHJvbm cgc3R5bGU9 J2ZvbnQtd2 VpZ2h0OiA2 MDA7Jz5EYW lseSBWaWRl byBOZXdzbG V0dGVyPC9z dHJvbmc+Pw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgPG EgaHJlZj0n aHR0cHM6Ly 93d3cuaW5z aWdodGZ1bH ZhbHVlLmNv bS9uZXdzbG V0dGVyLnBo cCcgdGFyZ2 V0PSdfYmxh bmsnIHN0eW xlPSdjb2xv cjogIzAwN0 JGRjsgdGV4 dC1kZWNvcm F0aW9uOiBu b25lOyBmb2 50LXdlaWdo dDogNTAwOy BtYXJnaW4t bGVmdDogNn B4Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg RmluZCBvdX QgbW9yZQog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9h PgogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg ICAgICAgIC AgICAgLS0+ CiAgICAgIC AgICAgICAg ICAgICAgPC 9kaXY+CiAg ICAgICAgIC AgICAgICA8 L2Rpdj4KIC AgICAgICAg ICAgPC9kaX Y+CiAgICAg ICAgICAgIA ==
What was the average Return on Equity ratio at the Pharma and biotechnology industry in the recent years?
GlaxoSmithKline

πŸ“–πŸ‘€ Want to read more about GlaxoSmithKline?

Sign up for free or log in

⚑ Instantly access "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free!

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3Mvbn VkRDBMNmt1 eFY4RFdsVX RKQjgud2Vi cCIgYWx0PS JHbGF4b1Nt aXRoS2xpbm UiIHRpdGxl PSJHbGF4b1 NtaXRoS2xp bmUiICBjbG Fzcz0iaW1n LWZsdWlkIi BoZWlnaHQ9 OTAgd2lkdG g9OTAgbG9h ZGluZz0nbG F6eScgc3R5 bGU9J2Jvcm Rlci1yYWRp dXM6IDZweD snPgoKICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdm bGV4OiAxOy B0ZXh0LWFs aWduOiBjZW 50ZXI7IG1h cmdpbi1sZW Z0OiA1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPHAg c3R5bGU9J2 ZvbnQtc2l6 ZTogMjZweD sgY29sb3I6 ICMzMzM7IG 1hcmdpbi1i b3R0b206ID E1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIPCf k5bwn5GAIF dhbnQgdG8g cmVhZCBtb3 JlIGFib3V0 IEdsYXhvU2 1pdGhLbGlu ZT8KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9c2 lnbnVwJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBiYW NrZ3JvdW5k LWNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Y29sb3I6IC NmZmY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBwYWRk aW5nOiAxMH B4IDIwcHg7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiA1 cHg7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICB0ZXh0LW RlY29yYXRp b246IG5vbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogYm 9sZDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG1hcmdp bi1yaWdodD ogMTBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRy YW5zaXRpb2 46IGJhY2tn cm91bmQtY2 9sb3IgMC4z cyBlYXNlOy cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dmVyPSd0aG lzLnN0eWxl LmJhY2tncm 91bmRDb2xv cj0iIzAwNT ZiMyInCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBvbm1v dXNlb3V0PS d0aGlzLnN0 eWxlLmJhY2 tncm91bmRD b2xvcj0iIz AwN0JGRiIn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bmb3IgZnJl ZQogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8c3Bh biBzdHlsZT 0nbWFyZ2lu OiAwIDhweD sgY29sb3I6 ICM1NTU7Jz 5vcjwvc3Bh bj4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxh IGhyZWY9J2 luZGV4LnBo cD9wYWdlPW xvZ2luJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogIzAw N0JGRjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHRleH QtZGVjb3Jh dGlvbjogdW 5kZXJsaW5l OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Zm9udC13ZW lnaHQ6IDUw MDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbG9nIG luCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCgogICAg ICAgICAgIC AgICAgICAg ICAgICA8cC BzdHlsZT0n bWFyZ2luLX RvcDogMTVw eDsgZm9udC 1zaXplOiAx M3B4OyBmb2 50LXdlaWdo dDogYm9sZD sgY29sb3I6 ICNkMzJmMm Y7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIOKaoSBJ bnN0YW50bH kgYWNjZXNz IDxpPiJUaG UgQ2hlY2ts aXN0IFZhbH VlIEludmVz dG9yIOKAlC BBIFNtYXJ0 ZXIgV2F5IH RvIFBpY2sg U3RvY2tzIj wvaT4g4oCU IGZyZWUhCi AgICAgICAg ICAgICAgIC AgICAgICAg IDwvcD4KCi AgICAgICAg ICAgICAgIC AgICAgICAg IDwhLS0KIC AgICAgICAg ICAgICAgIC AgICAgICAg PGRpdiBzdH lsZT0nbWFy Z2luLXRvcD ogMTJweDsg Zm9udC1zaX plOiAxM3B4 OyBjb2xvcj ogIzQ0NDsn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bub3cgYW5k IGdldCBvdX IgZnJlZSBl Qm9vayAKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIDxiPl RoZSBDaGVj a2xpc3QgVm FsdWUgSW52 ZXN0b3Ig4o CUIEEgU21h cnRlciBXYX kgdG8gUGlj ayBTdG9ja3 M8L2I+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICAgICAg ICAgICAgIC AtLT4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC EtLQogICAg ICAgICAgIC AgICAgICAg ICAgICA8ZG l2IHN0eWxl PSdtYXJnaW 4tdG9wOiAx NnB4OyBmb2 50LXNpemU6 IDE0cHg7IG NvbG9yOiAj NDQ0OyBmb2 50LWZhbWls eTogLWFwcG xlLXN5c3Rl bSwgQmxpbm tNYWNTeXN0 ZW1Gb250LC BTZWdvZSBV SSwgUm9ib3 RvLCBIZWx2 ZXRpY2EgTm V1ZSwgc2Fu cy1zZXJpZj sgbGluZS1o ZWlnaHQ6ID EuNjsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgSGF2 ZSB5b3UgaG VhcmQgYWJv dXQgb3VyIH Nob3J0IDxz dHJvbmcgc3 R5bGU9J2Zv bnQtd2VpZ2 h0OiA2MDA7 Jz5EYWlseS BWaWRlbyBO ZXdzbGV0dG VyPC9zdHJv bmc+PwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgPGEgaH JlZj0naHR0 cHM6Ly93d3 cuaW5zaWdo dGZ1bHZhbH VlLmNvbS9u ZXdzbGV0dG VyLnBocCcg dGFyZ2V0PS dfYmxhbmsn IHN0eWxlPS djb2xvcjog IzAwN0JGRj sgdGV4dC1k ZWNvcmF0aW 9uOiBub25l OyBmb250LX dlaWdodDog NTAwOyBtYX JnaW4tbGVm dDogNnB4Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgRmlu ZCBvdXQgbW 9yZQogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9hPgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgLS0+CiAg ICAgICAgIC AgICAgICAg ICAgPC9kaX Y+CiAgICAg ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgIA==
What was the average Gross Margin at the Pharma and biotechnology industry in the recent years?
GlaxoSmithKline

πŸ“–πŸ‘€ Want to read more about GlaxoSmithKline?

Sign up for free or log in

πŸ†“ Discover "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free eBook!

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3Mvbn VkRDBMNmt1 eFY4RFdsVX RKQjgud2Vi cCIgYWx0PS JHbGF4b1Nt aXRoS2xpbm UiIHRpdGxl PSJHbGF4b1 NtaXRoS2xp bmUiICBjbG Fzcz0iaW1n LWZsdWlkIi BoZWlnaHQ9 OTAgd2lkdG g9OTAgbG9h ZGluZz0nbG F6eScgc3R5 bGU9J2Jvcm Rlci1yYWRp dXM6IDZweD snPgoKICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdm bGV4OiAxOy B0ZXh0LWFs aWduOiBjZW 50ZXI7IG1h cmdpbi1sZW Z0OiA1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPHAg c3R5bGU9J2 ZvbnQtc2l6 ZTogMjZweD sgY29sb3I6 ICMzMzM7IG 1hcmdpbi1i b3R0b206ID E1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIPCf k5bwn5GAIF dhbnQgdG8g cmVhZCBtb3 JlIGFib3V0 IEdsYXhvU2 1pdGhLbGlu ZT8KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9c2 lnbnVwJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBiYW NrZ3JvdW5k LWNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Y29sb3I6IC NmZmY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBwYWRk aW5nOiAxMH B4IDIwcHg7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiA1 cHg7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICB0ZXh0LW RlY29yYXRp b246IG5vbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogYm 9sZDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG1hcmdp bi1yaWdodD ogMTBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRy YW5zaXRpb2 46IGJhY2tn cm91bmQtY2 9sb3IgMC4z cyBlYXNlOy cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dmVyPSd0aG lzLnN0eWxl LmJhY2tncm 91bmRDb2xv cj0iIzAwNT ZiMyInCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBvbm1v dXNlb3V0PS d0aGlzLnN0 eWxlLmJhY2 tncm91bmRD b2xvcj0iIz AwN0JGRiIn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bmb3IgZnJl ZQogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8c3Bh biBzdHlsZT 0nbWFyZ2lu OiAwIDhweD sgY29sb3I6 ICM1NTU7Jz 5vcjwvc3Bh bj4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxh IGhyZWY9J2 luZGV4LnBo cD9wYWdlPW xvZ2luJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogIzAw N0JGRjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHRleH QtZGVjb3Jh dGlvbjogdW 5kZXJsaW5l OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Zm9udC13ZW lnaHQ6IDUw MDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbG9nIG luCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCgogICAg ICAgICAgIC AgICAgICAg ICAgICA8cC BzdHlsZT0n bWFyZ2luLX RvcDogMTVw eDsgZm9udC 1zaXplOiAx M3B4OyBmb2 50LXdlaWdo dDogYm9sZD sgY29sb3I6 ICNkMzJmMm Y7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfhpMg RGlzY292ZX IgPGk+IlRo ZSBDaGVja2 xpc3QgVmFs dWUgSW52ZX N0b3Ig4oCU IEEgU21hcn RlciBXYXkg dG8gUGljay BTdG9ja3Mi PC9pPiDigJ QgZnJlZSBl Qm9vayEKIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9wPgoKIC AgICAgICAg ICAgICAgIC AgICAgICAg PCEtLQogIC AgICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdtYXJn aW4tdG9wOi AxMnB4OyBm b250LXNpem U6IDEzcHg7 IGNvbG9yOi AjNDQ0Oyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBT aWduIHVwIG 5vdyBhbmQg Z2V0IG91ci BmcmVlIGVC b29rIAogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgPGI+VG hlIENoZWNr bGlzdCBWYW x1ZSBJbnZl c3RvciDigJ QgQSBTbWFy dGVyIFdheS B0byBQaWNr IFN0b2Nrcz wvYj4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9kaXY+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC 0tPgogICAg ICAgICAgIC AgICAgICAg ICAgICA8IS 0tCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxkaX Ygc3R5bGU9 J21hcmdpbi 10b3A6IDE2 cHg7IGZvbn Qtc2l6ZTog MTRweDsgY2 9sb3I6ICM0 NDQ7IGZvbn QtZmFtaWx5 OiAtYXBwbG Utc3lzdGVt LCBCbGlua0 1hY1N5c3Rl bUZvbnQsIF NlZ29lIFVJ LCBSb2JvdG 8sIEhlbHZl dGljYSBOZX VlLCBzYW5z LXNlcmlmOy BsaW5lLWhl aWdodDogMS 42Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBIYXZl IHlvdSBoZW FyZCBhYm91 dCBvdXIgc2 hvcnQgPHN0 cm9uZyBzdH lsZT0nZm9u dC13ZWlnaH Q6IDYwMDsn PkRhaWx5IF ZpZGVvIE5l d3NsZXR0ZX I8L3N0cm9u Zz4/CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICA8YSBocm VmPSdodHRw czovL3d3dy 5pbnNpZ2h0 ZnVsdmFsdW UuY29tL25l d3NsZXR0ZX IucGhwJyB0 YXJnZXQ9J1 9ibGFuaycg c3R5bGU9J2 NvbG9yOiAj MDA3QkZGOy B0ZXh0LWRl Y29yYXRpb2 46IG5vbmU7 IGZvbnQtd2 VpZ2h0OiA1 MDA7IG1hcm dpbi1sZWZ0 OiA2cHg7Jz 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBGaW5k IG91dCBtb3 JlCiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC A8L2E+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICAgICAg ICAgICAgIC AtLT4KICAg ICAgICAgIC AgICAgICAg ICA8L2Rpdj 4KICAgICAg ICAgICAgIC AgIDwvZGl2 PgogICAgIC AgICAgICA8 L2Rpdj4KIC AgICAgICAg ICAg
What was the average Operating Margin at the Pharma and biotechnology industry in the recent years?
GlaxoSmithKline

πŸ“–πŸ‘€ Want to read more about GlaxoSmithKline?

Sign up for free or log in

πŸ“– Get insights from "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" now!

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3Mvbn VkRDBMNmt1 eFY4RFdsVX RKQjgud2Vi cCIgYWx0PS JHbGF4b1Nt aXRoS2xpbm UiIHRpdGxl PSJHbGF4b1 NtaXRoS2xp bmUiICBjbG Fzcz0iaW1n LWZsdWlkIi BoZWlnaHQ9 OTAgd2lkdG g9OTAgbG9h ZGluZz0nbG F6eScgc3R5 bGU9J2Jvcm Rlci1yYWRp dXM6IDZweD snPgoKICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdm bGV4OiAxOy B0ZXh0LWFs aWduOiBjZW 50ZXI7IG1h cmdpbi1sZW Z0OiA1cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPHAg c3R5bGU9J2 ZvbnQtc2l6 ZTogMjZweD sgY29sb3I6 ICMzMzM7IG 1hcmdpbi1i b3R0b206ID E1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIPCf k5bwn5GAIF dhbnQgdG8g cmVhZCBtb3 JlIGFib3V0 IEdsYXhvU2 1pdGhLbGlu ZT8KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9w PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9c2 lnbnVwJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBiYW NrZ3JvdW5k LWNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Y29sb3I6IC NmZmY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBwYWRk aW5nOiAxMH B4IDIwcHg7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiA1 cHg7CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICB0ZXh0LW RlY29yYXRp b246IG5vbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogYm 9sZDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG1hcmdp bi1yaWdodD ogMTBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRy YW5zaXRpb2 46IGJhY2tn cm91bmQtY2 9sb3IgMC4z cyBlYXNlOy cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dmVyPSd0aG lzLnN0eWxl LmJhY2tncm 91bmRDb2xv cj0iIzAwNT ZiMyInCiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBvbm1v dXNlb3V0PS d0aGlzLnN0 eWxlLmJhY2 tncm91bmRD b2xvcj0iIz AwN0JGRiIn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg U2lnbiB1cC Bmb3IgZnJl ZQogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2E+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8c3Bh biBzdHlsZT 0nbWFyZ2lu OiAwIDhweD sgY29sb3I6 ICM1NTU7Jz 5vcjwvc3Bh bj4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxh IGhyZWY9J2 luZGV4LnBo cD9wYWdlPW xvZ2luJyBz dHlsZT0nCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogIzAw N0JGRjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHRleH QtZGVjb3Jh dGlvbjogdW 5kZXJsaW5l OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg Zm9udC13ZW lnaHQ6IDUw MDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbG9nIG luCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCgogICAg ICAgICAgIC AgICAgICAg ICAgICA8cC BzdHlsZT0n bWFyZ2luLX RvcDogMTVw eDsgZm9udC 1zaXplOiAx M3B4OyBmb2 50LXdlaWdo dDogYm9sZD sgY29sb3I6 ICNkMzJmMm Y7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfk5Yg R2V0IGluc2 lnaHRzIGZy b20gPGk+Il RoZSBDaGVj a2xpc3QgVm FsdWUgSW52 ZXN0b3Ig4o CUIEEgU21h cnRlciBXYX kgdG8gUGlj ayBTdG9ja3 MiPC9pPiBu b3chCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwv cD4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwh LS0KICAgIC AgICAgICAg ICAgICAgIC AgICAgPGRp diBzdHlsZT 0nbWFyZ2lu LXRvcDogMT JweDsgZm9u dC1zaXplOi AxM3B4OyBj b2xvcjogIz Q0NDsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgU2ln biB1cCBub3 cgYW5kIGdl dCBvdXIgZn JlZSBlQm9v ayAKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IDxiPlRoZS BDaGVja2xp c3QgVmFsdW UgSW52ZXN0 b3Ig4oCUIE EgU21hcnRl ciBXYXkgdG 8gUGljayBT dG9ja3M8L2 I+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC AgICAgICAg ICAgICAtLT 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPCEtLQ ogICAgICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdt YXJnaW4tdG 9wOiAxNnB4 OyBmb250LX NpemU6IDE0 cHg7IGNvbG 9yOiAjNDQ0 OyBmb250LW ZhbWlseTog LWFwcGxlLX N5c3RlbSwg QmxpbmtNYW NTeXN0ZW1G b250LCBTZW dvZSBVSSwg Um9ib3RvLC BIZWx2ZXRp Y2EgTmV1ZS wgc2Fucy1z ZXJpZjsgbG luZS1oZWln aHQ6IDEuNj snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgSGF2ZSB5 b3UgaGVhcm QgYWJvdXQg b3VyIHNob3 J0IDxzdHJv bmcgc3R5bG U9J2ZvbnQt d2VpZ2h0Oi A2MDA7Jz5E YWlseSBWaW RlbyBOZXdz bGV0dGVyPC 9zdHJvbmc+ PwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg PGEgaHJlZj 0naHR0cHM6 Ly93d3cuaW 5zaWdodGZ1 bHZhbHVlLm NvbS9uZXdz bGV0dGVyLn BocCcgdGFy Z2V0PSdfYm xhbmsnIHN0 eWxlPSdjb2 xvcjogIzAw N0JGRjsgdG V4dC1kZWNv cmF0aW9uOi Bub25lOyBm b250LXdlaW dodDogNTAw OyBtYXJnaW 4tbGVmdDog NnB4Oyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgRmluZCBv dXQgbW9yZQ ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9hPgogICAg ICAgICAgIC AgICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgICAgICAg ICAgICAgLS 0+CiAgICAg ICAgICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg IA==
GlaxoSmithKline

πŸ’¬ Explore over 100 Q&As related to GlaxoSmithKline's industry!

Sign up for free or log in

πŸ”“ Unlock our free guide: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

© 2024 - 2025 InsightfulValue.com. All rights reserved. Newsletter
Legal